Opus Genetics, Inc. (NASDAQ:IRD) reported on September 9 that all five low-dose BIRD-1 participants showed clinically ...
Zacks Investment Research on MSN
SOPHiA GENETICS (SOPH) moves 7.0% higher: Will this strength last?
SOPHiA GENETICS SA SOPH shares rallied 7% in the last trading session to close at $8.53. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...
These genetic variants aren’t a crystal ball, but they can predict personality traits and potential life outcomes.
SOPHiA GENETICS is back in focus as analysts reset their central price views, with fair value moving from US$9.00 to US$9.75. Recent research linking the company’s role in data driven oncology and ...
Understanding gene regulation may be key to interpreting human disease genetics. Genes are regulated in part by stretches of ...
Myriad Genetics Inc. company and executive profile by Barron's. View the latest MYGN company infomation and executive bios.
Opus Genetics (IRD) receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in ...
Hendrix Genetics Swine will move forward as the Swine Business Unit of Hendrix Genetics with a dedicated focus on serving swine producers worldwide.
A person’s genetic background can strongly influence not only whether they will develop cancer but also how that cancer progresses, suggesting that genetics plays a much larger role in cancer ...
A genetic testing company's data breach is particularly problematic for people undergoing IVF, experts warned.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results